Synthesis, anti-inflammatory activities and docking studies of amide derivatives of meclofenamic acid

被引：0
作者：
Tamanna Narsinghani
Rajesh Sharma
机构：
[1] Devi Ahilya Vishwavidyalaya,School of Pharmacy
来源：
Chemical Papers | 2017年 / 71卷
关键词：
NSAIDs; COX; Meclofenamic acid; Anti-inflammatory activity; Docking;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
NSAIDs constitute a heterogeneous class of pharmacological agents widely prescribed for the treatment of inflammation, pain and edema, as well as osteoarthritis, rheumatoid arthritis and musculoskeletal disorders. This class of drugs has proved efficacious on account of their analgesic, anti-pyretic and anti-inflammatory activities, but gastrointestinal toxicity exists as the biggest problem associated with their chronic use. Many attempts have been made to structurally modify conventional NSAIDs as selective COX-2 inhibitors based on the old and still prevalent common belief that selective inhibition of COX-2 would provide safer NSAIDs. The present work thus focused on the synthesis of amide derivatives of one of the conventional non-selective NSAID, meclofenamic acid utilizing the one pot procedure involving a selective agent, bis (2-oxo-3-oxazolidinyl) phosphonic chloride. The synthesized compounds were tested for their in vivo inflammatory activity using carrageenan rat paw edema assay, and were subsequently docked on COX-2 PDB code 4COX to have better insights into their mechanism of action. The amide derivative with N-4-methoxybenzyl moiety (TSN4) proved to have anti-inflammatory potential (72.8%) better than meclofenamic acid (56.75%). This compound also docked with the highest dock score among the synthesized compounds and was found to have both hydrogen bonding with Arg120 and Tyr355 and hydrophobic interactions with Val349, Leu352, Ser353, Tyr385, Trp387, Met522, Val523, Ala527 and Ser530. N-4-methoxybenzyl amide derivative (TSN4) followed by benzyl amide derivative (TSN1) of meclofenamic acid were identified as potential anti-inflammatory compounds in both in vivo and in silico studies.
引用
收藏
页码：857 / 868
页数：11
相关论文
共 104 条
[1]  
Bhattacharyya DK(1996)Involvement of arginine 120, glutamate 524, and tyrosine 355 in the binding of arachidonate and 2-phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1 J Biol Chem 271 2179-2184
[2]  
Lecomte M(2012)Design, synthesis, antinociceptive and anti-inflammatory activities of novel piroxicam analogues Molecules 17 14126-14145
[3]  
Rieke CJ(2006)Ester derivatives of flurbiprofen and 2-[1,1′-biphenyl-4-yl]acetic acid: a potential approach to reduce local gastrointestinal toxicity Chem Biodivers 3 1238-1248
[4]  
Garavito M(2009)Lonazolac analogues: molecular modeling, synthesis, and in vivo anti-inflammatory activity Med Chem Res 18 725-744
[5]  
Smith WL(2000)Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors J Med Chem 43 2860-2870
[6]  
de Miranda AS(2000)Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors Proc Natl Acad Sci 97 925-930
[7]  
Junior WB(2002)Amide derivatives of meclofenamic acid as selective cyclooxygenase-2 inhibitors Bioorg Med Chem Lett 12 521-524
[8]  
Da Silva YKC(2005)Indolyl esters and amides related to indomethacin are selective COX-2 inhibitors Bioorg Med Chem 13 6810-6822
[9]  
Alexandre-Moreira MS(2015)Origin of the enigmatic stepwise tight-binding inhibition of cyclooxygenase-1 Biochemistry 54 7283-7291
[10]  
de Paula Castro R(1996)Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents Nature 384 644-648
12345678910